Dabigatran falsely elevates point of care international normalized ratio results

American Journal of Medicine

Volumn 124, Issue 8, 2011, Pages

  DeRemer, Christina E ^a   Gujral, Jaspal S ^a   Thornton, John W ^a   Sorrentino, Robert A ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; CASE REPORT; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FUNCTION; LETTER; MALE; PARTIAL THROMBOPLASTIN TIME; POINT OF CARE TESTING; PRIORITY JOURNAL;

EID: 84863811351     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.01.025     Document Type: Letter

References (2)

1. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151.
2. van Ryn J, Stangier J, Haertter S, et al. Dabigatran etexilate-a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost. 2010;103:116-127. Epub 2010 Mar. 29.